Their findings suggest that SLC16A1-AS1 acts as a tumor suppressor by regulating the miR-301b-3p/CHD5 axis, impacting cell viability, proliferation, apoptosis, invasion, radiosensitivity, and the epithelial-mesenchymal transition (EMT) process. The gene discussed is SLC16A1; the disease is neoplasm.